Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mycobacterium-avium complex

D S Rubin1, J J Rahal

  • 1New York Hospital Medical Center of Queens, Flushing.

Infectious Disease Clinics of North America
|June 1, 1994
PubMed
Summary
This summary is machine-generated.

Disseminated MAC (mycobacterium avium complex) is a significant threat for AIDS patients with low CD4 counts. Prophylaxis and targeted multi-drug therapy are crucial for managing this opportunistic infection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Polymyxin B-Resistant Acinetobacter baumannii Clinical Isolate Susceptible to Recombinant BPI and Cecropin P1.

Antimicrobial agents and chemotherapy·2006
Same author

Acinetobacter.

Seminars in respiratory and critical care medicine·2005
Same author

Controversies in AIDS treatment. Proceedings from CME conference sponsored by Cornell University Medical College and the American Foundation for AIDS Research (AmFAR). November 8, 1997. Faculty roundtable discussion.

AIDS patient care and STDs·2004
Same author

Short-term therapy for intravascular catheter-related Staphylococcus aureus bacteremia.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2001
Same author

Nosocomial transmission of imipenem-resistant Pseudomonas aeruginosa following bronchoscopy associated with improper connection to the Steris System 1 processor.

Infection control and hospital epidemiology·2001
Same author

Extended-spectrum beta-lactamases: how big is the problem?

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2001
Same journal

Prevention and Control of Clostridioides difficile Infection for the Infectious Diseases Clinician.

Infectious disease clinics of North America·2026
Same journal

Infection Control Strategies to Prevent Emergence and Transmission of Resistant Gram-Negative Bacteria.

Infectious disease clinics of North America·2026
Same journal

Preventing the Spread of Tuberculosis in Health Care Settings.

Infectious disease clinics of North America·2026
Same journal

Threats to Success: Principles of Infection Prevention and Control in Health Care Settings, Part 2: Device and Pathogen Management.

Infectious disease clinics of North America·2026
Same journal

Ventilator-Associated Events: Surveillance and Prevention.

Infectious disease clinics of North America·2026
Same journal

Nosocomial Fungal Infections: Epidemiology, Control Strategies, and Prevention of Candida and Other Yeasts.

Infectious disease clinics of North America·2026
See all related articles

Area of Science:

  • Infectious Diseases
  • Immunology
  • HIV/AIDS Research

Background:

  • Mycobacterium avium complex (MAC) is a common opportunistic infection in patients with Acquired Immunodeficiency Syndrome (AIDS).
  • Prolonged immunodeficiency in advanced HIV infection leads to increased susceptibility to disseminated MAC (DMAC).

Purpose of the Study:

  • To highlight the growing clinical importance of MAC as an opportunistic pathogen in the context of advanced HIV.
  • To emphasize the role of CD4 T-cell counts in DMAC risk and the need for prophylaxis.
  • To outline current therapeutic strategies for DMAC in immunocompromised patients.

Main Methods:

  • Literature review and synthesis of clinical data regarding MAC in AIDS patients.
  • Analysis of risk factors, particularly CD4 T-cell counts.

Related Experiment Videos

  • Evaluation of therapeutic regimens for DMAC.

    • Main Results:

    • Disseminated MAC is prevalent in a significant proportion of AIDS patients.
    • A CD4 count below 100 cells/mm³ is the primary risk factor for DMAC.
    • Prophylaxis can substantially decrease DMAC incidence in advanced HIV.
    • Multi-drug regimens, including macrolides, are indicated for DMAC treatment.

    Conclusions:

    • DMAC is an emerging clinical challenge in the growing population of long-term survivors with HIV.
    • Effective prophylaxis and judicious multi-drug therapy are essential for managing DMAC.
    • Minimizing drug toxicity and interactions is critical when treating debilitated patients with DMAC.